Rosane Bittencourt

Universidade Federal do Rio Grande do Sul — Brazil

Medicine · Health Sciences

18h-index1.1kcitations140works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(49), Multiple Myeloma Research and Treatments(43), Retinoids in leukemia and cellular processes(35), Acute Lymphoblastic Leukemia research(26), Protein Degradation and Inhibitors(19)

Publications140 total

Early flow cytometry-based MRD predicts relapse in intermediate-risk AML from low- and middle-income countries
Blood·2025
TREATMENT PATTERNS AND OUTCOMES IN THE SECOND AND THIRD LINES AND AFTER TRIPLE-CLASS EXPOSURE: SUBANALYSIS OF THE LATIN AMERICAN MULTIPLE MYELOMA REGISTRY STUDY (MYLACRE)
Hematology Transfusion and Cell Therapy·2025Open Access
Treatment Patterns and Outcomes in the Second and Third Lines and After Triple-class Exposure: Subanalysis of the Latin American Multiple Myeloma Registry Study (MYLACRE)
Clinical Lymphoma Myeloma & Leukemia·2025
Daratumumab, Bortezomib, Thalidomide and Dexamethasone Followed by Lenalidomide Maintenance in Transplant-Eligible Multiple Myeloma Patients: Overall Survival Comparison with the CASSIOPEIA Trial
Clinical Lymphoma Myeloma & Leukemia·2025
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis
Blood Advances·2025Open Access
Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study
Blood Advances·2024· 2 citedOpen Access
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a chemotherapy plus ATRA cohort from an international consortium
Haematologica·2024Open Access
Brazilian Real-Life Experience of Multiple Myeloma (MMyBRAve): Improvement in Outcomes, But Remaining Diagnostic and Therapeutic Gaps
Clinical Lymphoma Myeloma & Leukemia·2024· 2 citedOpen Access
MULTI-OMIC ANALYSIS OF MULTIPLE MYELOMA BY T(11;14) STATUS
Hematology Transfusion and Cell Therapy·2024Open Access
P-427 Real-world Prevalence and Multi-omic Analysis of t(11;14)-Positive Multiple Myeloma: Final Analysis from the MEDICI Study
Clinical Lymphoma Myeloma & Leukemia·2024· 1 cited
P-327 Real-World Data on the Daratumumab Plus Bortezomib, Thalidomide and Dexamethasone Followed by Lenalidomide Maintenance for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients
Clinical Lymphoma Myeloma & Leukemia·2024
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia
Blood·2024· 10 cited
Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy
Hematology Transfusion and Cell Therapy·2024· 7 citedOpen Access
A Brazilian Real-Life Experience of Multiple Myeloma Patients: Final Results from the Mmybrave Multicenter Observational Study
SSRN Electronic Journal·2024Open Access
Are hospitalized older patients different? Scales, scores, lab values, and outcomes
Clinical Nutrition ESPEN·2023Open Access
Real World Evidence- the Proportion of Myeloma Patients' Death Due to Early Progression
Blood·2023
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality –cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)
Hematology Transfusion and Cell Therapy·2023· 6 citedOpen Access
P-140 Multiple myeloma in Latin America cancer registry: the MYLACRE study
Clinical Lymphoma Myeloma & Leukemia·2023
P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY
HemaSphere·2023Open Access
P954: MULTIPLE MYELOMA IN LATIN AMERICA CANCER REGISTRY: THE MYLACRE STUDY
HemaSphere·2023· 3 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Eduardo Magalhães Rego(20), Kátia Bórgia Barbosa Pagnano(19), Evandro M. Fagundes(19), Raul Antônio Morais Melo(15), Ricardo Pasqüini(15), Maria de Lourdes Chauffaille(14), Miguel Á. Sanz(14), Raul C. Ribeiro(13), Bob Löwenberg(13), Vânia Hungria(13), Francesco Lo‐Coco(12), Rafael Henriques Jácomo(11), Arnold Ganser(11), Nancy Berliner(11), Ângelo Maiolino(11), Martin S. Tallman(10), Carlos Chiattone(9), Antonio R. Lucena‐Araujo(9), Edvan de Queiroz Crusoé(9), Haesook T. Kim(8)